Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Total 10000 results

Kinex Pharmaceuticals Inc.

Completed

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Acute Myelogenous Leukemia

United States
Lebanese American University

Unknown

Melanole, a Dietary Supplement, for the Treatment of Gastroesophageal Reflux Disease (GERDMeDS)

GERD

Lebanon
Bayer

Completed

An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension

Hypertension, Pulmonary

Germany
Genzyme, a Sanofi Company

Terminated

A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

United States
Lawson Health Research Institute

Terminated

Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Canada
Hellenic Cooperative Oncology Group

Completed

Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors

Breast Tumors | Brain Metastases | Lung Tumors

Greece
University Hospital of Mont-Godinne
GlaxoSmithKline; Université Catholique de Louvain

Completed

Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study (CERETI)

Epilepsy

Belgium
National Institute of Diabetes and Digestive and...

Completed

High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1

Chronic Hepatitis C

United States
Shiraz University of Medical Sciences

Completed

Use of PRP in Treatment of Mandibular Traumatic Bone Cyst (TBC)

Traumatic Bone Cyst

Iran, Islamic Republic of
Univar BV
Aptiv Solutions

Completed

A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Wilson's Disease

Germany
ThromboGenics
Bacchus Vascular

Terminated

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT (MAX-DVT)

Deep Vein Thrombosis

Ireland
Groupe Francophone des Myelodysplasies
Genzyme, a Sanofi Company

Completed

Clofarabine in High Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

France
Gilead Sciences

Terminated

DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension (Darusentan)

Hypertension

United States, Sweden, Argentina, Denmark, Brazil, Canada, France, United Kingdom
Shanghai Zhongshan Hospital

Completed

Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis

Advanced Gastric Cancer

China
Asan Medical Center

Completed

Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial

Gastric Cancer

Korea, Republic of
Fudan University
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer

Breast Neoplasms

China
All India Institute of Medical Sciences, New Delhi

Completed

A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots (RAFT-PVT)

Prosthetic Valve Thrombosis
Copenhagen University Hospital at Herlev

Completed

Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? (Bismuth-PBH)

Leukemia | Multiple Myeloma | Hematological Malignancies | Hematological Diseases | Blood Diseases | Malignant Lymphoma

Denmark
Mayo Clinic
Arizona State University; Takeda Pharmaceuticals North America, Inc.

Completed

Intestinal Microecology in Chronic Constipation

Irritable Bowel Syndrome | Other Constipation

United States
Pharmacyclics LLC.

Completed

A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer

Lymphoma | Leukemia | Multiple Myeloma | Hodgkin Disease | Non-Hodgkin's Lymphoma | Lymphocytic

United States
Melbourne Health
Sanofi; National Heart Foundation, Australia

Terminated

The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.

Deep Vein Thrombosis

Australia
Sanofi
Hoffmann-La Roche

Completed

Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer (CLASSIC)

Stomach Neoplasms

Korea, Republic of, Taiwan, China
Pfizer

Completed

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

Arthritis, Rheumatoid

United States, Czech Republic, Korea, Republic of, Mexico, Italy, India, Slovakia, Poland, Japan, Dominican Republic, Finland, Puerto Rico, Spain, Argentina, Bulgaria, Hungary, Brazil, Greece, Canada, Ukraine, Chile
GlaxoSmithKline

Completed

Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

Epilepsy, Partial
Gilead Sciences

Completed

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

Chronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Lymphoma, Non-Hodgkin (NHL)

United States
M.D. Anderson Cancer Center
ICN Pharmaceuticals

Completed

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

Hematological Malignancies

United States
University Hospital, Strasbourg, France
Sanofi; French State

Unknown

Thromboprophylaxis and Bariatric Surgery

Thromboembolism

France
Genta Incorporated

Unknown

Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Advanced Non-resectable Breast Cancer

United States
Bristol-Myers Squibb

Completed

Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib

Chronic Myeloid Leukemia | Philadelphia-Positive Myeloid Leukemia

Belgium, Netherlands, Spain, United States, Italy, Canada, France, Germany, Peru, Singapore, United Kingdom, Australia, Sweden, Finland, Israel, Ireland, Denmark, Korea, Republic of, Norway, Austria, South Africa, Switzerland
AstraZeneca

Withdrawn

A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer

Breast Cancer

Italy
AstraZeneca

Completed

A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme

Glioblastoma

Sweden
Sanofi

Completed

Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving Enoxaparin (LIFENOX)

Acute Illness

Brazil, China, India, Malaysia, Philippines, Tunisia, Mexico, Korea, Republic of, Hong Kong
Pfizer

Completed

Pharmacokinetics And Safety Study Of Two CP-690,550 Controlled Release Formulation Following Single Dose In Healthy Volunteers

Healthy

Singapore
Egyptian Foundation For Cancer Research

Completed

Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma (MERITS)

Metastatic Renal Cell Carcinoma

Egypt
Sanofi

Completed

Enoxaparin in Acute Venous Thromboembolic Disease

Venous Thrombosis

Turkey
Medical University of Vienna

Completed

Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients

Cancer

Austria
Hamilton Health Sciences Corporation
Actelion

Unknown

A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

Hypertension, Pulmonary | Connective Tissue Disease

Canada
Sanofi

Completed

HENOX: Enoxaparine in Hemodialysis

Hemodialysis

Thailand
University of Michigan Rogel Cancer Center
Hoffmann-La Roche

Terminated

Radiation Therapy With Capecitabine in Rectal Cancer

Rectal Cancer

United States
University of Washington
Schering-Plough

Completed

Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer

Soft Tissue Sarcoma | Breast Cancer

United States
University Medicine Greifswald

Unknown

Impact of Heparin on the Need for Mechanical Ventilation in Neonates

Hemorrhage | Respiration, Artificial

Germany
Bristol-Myers Squibb

Completed

A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV

HIV Infections | Chickenpox

United States
Radboud University Medical Center

Unknown

The Efficacy and Safety of ITF2357 in AIS

Autoinflammatory Syndromes | HIDS | TRAPS | Schnitzler's Syndrome

Netherlands
Kyoto University, Graduate School of Medicine

Unknown

Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure

Liver Failure, Acute

Japan
National Center for Research Resources (NCRR)
University of Texas

Completed

Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias

Porphyria

United States
National Center for Research Resources (NCRR)
Ohio State University

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders

Paralysis, Hyperkalemic Periodic | Paramyotonia Congenita | Hypokalemic Periodic Paralysis
Monash Medical Centre
Monash University

Recruiting

FASST - Fetal Alcohol Spectrum Stimulant Trial (FASST)

Fetal Alcohol Spectrum Disorders

Australia
Murdoch Childrens Research Institute
Baylor College of Medicine; Children's Hospital of Philadelphia; Boston Children... and other collaborators

Active, not recruiting

A Study to Compare the Long-term Outcomes After Two Different Anaesthetics (TREX)

Child Development | Anesthesia | Neurotoxicity

United States, Australia, Italy, Spain
Vanguard Research Group
Otsuka America Pharmaceutical

Completed

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics (PRELAPSE)

Schizophrenia

United States
KK Women's and Children's Hospital

Completed

Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy

Anesthesia | Ketamine | Hysterectomy | Morphine

Singapore

Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations